Highlights the report of the U.S. Government Accounting Office regarding Medicare payments to oncologists for chemotherapy drugs for 2005. Claim that payments will exceed the actual costs; Plan to review chemotherapy drugs to ensure that final payment rates accurately reflect the average sales prices for the drugs.